Association between seropositivity and discontinuation of tumor necrosis factor inhibitors due to ineffectiveness in rheumatoid arthritis

被引：0

作者：

Yoshikazu Ogawa

Nobunori Takahashi

Atsushi Kaneko

Yuji Hirano

Yasuhide Kanayama

Yuichiro Yabe

Takeshi Oguchi

Takayoshi Fujibayashi

Hideki Takagi

Masahiro Hanabayashi

Koji Funahashi

Masatoshi Hayashi

Seiji Tsuboi

Shuji Asai

Nobuyuki Asai

Takuya Matsumoto

Yasumori Sobue

Naoki Ishiguro

Toshihisa Kojima

机构：

[1] Nakatsugawa Municipal General Hospital,Department of Orthopaedic Surgery

[2] Nagoya University Graduate School of Medicine,Department of Orthopaedic Surgery

[3] Nagoya Medical Center,Department of Orthopedic Surgery and Rheumatology

[4] Toyohashi Municipal Hospital,Department of Rheumatology

[5] Toyota Kosei Hospital,Department of Orthopedic Surgery

[6] Tokyo Shinjuku Medical Center,Department of Rheumatology

[7] Anjo Kosei Hospital,Department of Orthopedic Surgery

[8] Konan Kosei Hospital,Department of Orthopedic Surgery

[9] Nagoya Central Hospital,Department of Orthopedic Surgery

[10] Ichinomiya Municipal Hospital,Department of Orthopedic Surgery

[11] Kariya–Toyota General Hospital,Department of Orthopedic Surgery

[12] Nagano Red Cross Hospital,Department of Rheumatology

[13] Shizuoka Kosei Hospital,Department of Orthopedic Surgery

来源：

Clinical Rheumatology | 2019年 / 38卷

关键词：

Biological therapy; Rheumatoid factor; Tumor necrosis factor; Survival analysis;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：2757 / 2763

页数：6

共 50 条

[1] Association between seropositivity and discontinuation of tumor necrosis factor inhibitors due to ineffectiveness in rheumatoid arthritis
Ogawa, Yoshikazu
Takahashi, Nobunori
Kaneko, Atsushi
Hirano, Yuji
Kanayama, Yasuhide
Yabe, Yuichiro
Oguchi, Takeshi
Fujibayashi, Takayoshi
Takagi, Hideki
Hanabayashi, Masahiro
Funahashi, Koji
Hayashi, Masatoshi
Tsuboi, Seiji
Asai, Shuji
Asai, Nobuyuki
Matsumoto, Takuya
Sobue, Yasumori
Ishiguro, Naoki
Kojima, Toshihisa
CLINICAL RHEUMATOLOGY, 2019, 38 (10) : 2757 - 2763
[2] ASSOCIATION BETWEEN RHEUMATOID FACTOR STATUS AND DISCONTINUATION OF TUMOR NECROSIS FACTOR INHIBITORS DUE TO INEFFECTIVENESS IN RHEUMATOID ARTHRITIS
Ogawa, Yoshikazu
Takahashi, Nobunori
Kojima, Toshihisa
Ishiguro, Naoki
ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 722 - 723
[3] Association Between Seropositivity and Discontinuation of Tumor Necrosis Factor Inhibitors Due to Insufficient Response in Rheumatoid Arthritis
Ogawa, Yoshikazu
Takahashi, Nobunori
Kojima, Toshihisa
Ishiguro, Naoki
ARTHRITIS & RHEUMATOLOGY, 2019, 71
[4] Predictors of discontinuation of tumor necrosis factor inhibitors in patients with rheumatoid arthritis
Agarwal, Sandeep K.
Glass, Roberta J.
Shadick, Nancy A.
Coblyn, Jonathan S.
Anderson, Ronald J.
Maher, Nancy E.
Weinblatt, Michael E.
Solomon, Daniel H.
JOURNAL OF RHEUMATOLOGY, 2008, 35 (09) : 1737 - 1744
[5] ASSOCIATION BETWEEN SEROPOSITIVITY AND DISCONTINUATION OF INFLIXIMAB IN RHEUMATOID ARTHRITIS
Ogawa, Y.
Takahashi, N.
Kojima, T.
Ishiguro, N.
ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 626 - 627
[6] Tumor necrosis factor inhibitors for rheumatoid arthritis
Dentener, Mieke A.
Wouters, Emiel F. M.
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (19): : 2047 - 2048
[7] Inhibitors of tumor necrosis factor for rheumatoid arthritis
Moreland, LW
JOURNAL OF RHEUMATOLOGY, 1999, 26 : 7 - 15
[8] Tumor necrosis factor inhibitors for rheumatoid arthritis
Scott, D. L.
Kingsley, G. H.
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (07): : 704 - 712
[9] Tumor necrosis factor inhibitors for rheumatoid arthritis
Jones, RE
Moreland, LW
BULLETIN ON THE RHEUMATIC DISEASES, 1999, 48 (03) : 1 - 4
[10] Discontinuation of Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis and Psoriasis
Wolfe, Sophia
Cheng, Elizabeth
Ganuthula, Kavya
Fang, Meika
Kerr, Gail
Walsh, Jessica
Chang, Elizabeth
Raychaudhuri, Siba
Brees, Kyle
Dellavalle, Robert
Reimold, Andreas
Caplan, Liron
ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3825 - 3827

← 1 2 3 4 5 →